STOCK TITAN

Daxor (NASDAQ: DXR) furnishes current investor presentation in 8-K

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Daxor Corporation filed a current report to share its latest investor presentation with the market. The company used an 8-K under the "Other Events" section to formally furnish this material.

The filing states that the current investor presentation is attached as Exhibit 99.1, making it part of the public record. Daxor’s common stock, with a par value of $0.01 per share, trades on Nasdaq under the symbol DXR.

Positive

  • None.

Negative

  • None.
false 0000027367 0000027367 2026-01-22 2026-01-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) January 23, 2026

 

Daxor Corporation

 

(Exact name of registrant as specified in its charter)

 

New York   811-22684   13-2682108

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

107 Meco Lane, Oak Ridge, TN   37830
(Address of principal executive offices)   (Zip Code)

 

212-330-8500

 

Registrant’s telephone number, including area code

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock $0.01 par value   DXR   Nasdaq

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

 

 

 

 

Item 8.01 – Other Events

 

Attached hereto as Exhibit 99.1 is Daxor Corporation’s current investor presentation.

 

Item 9.01 Exhibits

 

(d)Exhibits. The following exhibit is filed with this Current Report on Form 8-K:

 

No.   Description
     
99.1   Attached hereto is an investor presentation.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  DAXOR CORPORATION
  (Registrant)
   
Date: January 23, 2026 By: /s/ Robert J. Michel
  Name: Robert J. Michel
  Title: Chief Financial Officer

 

 

 

 

FAQ

What did Daxor Corporation (DXR) report in this 8-K filing?

Daxor Corporation reported that its current investor presentation is being furnished as Exhibit 99.1 under the "Other Events" section.

What is included as Exhibit 99.1 in Daxor (DXR)'s 8-K?

Exhibit 99.1 consists of Daxor Corporation’s current investor presentation, which is attached to the 8-K.

Under which item of the 8-K did Daxor (DXR) provide the investor presentation?

The investor presentation is furnished under Item 8.01, labeled "Other Events."

On which exchange is Daxor Corporation (DXR) common stock listed?

Daxor Corporation’s common stock, $0.01 par value, is listed on the Nasdaq under the trading symbol DXR.

Who signed this Daxor Corporation (DXR) 8-K filing?

The 8-K was signed on behalf of Daxor Corporation by Robert J. Michel, Chief Financial Officer.

What other exhibit is referenced in this Daxor (DXR) 8-K?

The filing also references Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.
DAXOR CORP

NASDAQ:DXR

DXR Rankings

DXR Latest News

DXR Latest SEC Filings

DXR Stock Data

72.61M
2.14M
56.64%
2.01%
0.77%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK